Incyte Corp (NASDAQ:INCY)

69.20
Delayed Data
As of 4:00pm ET
 -0.91 / -1.30%
Today’s Change
60.23
Today|||52-Week Range
140.11
-26.93%
Year-to-Date

Today’s Trading

Previous close70.11
Today’s open70.11
Day’s range69.02 - 70.11
Volume1,040,679
Average volume (3 months)2,368,368
Market cap$14.9B
Data as of 4:00pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)-383.33%
Earnings growth (this year)+126.22%
Earnings growth (next 5 years)+63.70%
Revenue growth (last year)+38.93%
P/E ratioNM
Price/Sales12.61
Price/Book9.12

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.13-0.15%
ALXNAlexion Pharmaceutic...+0.07+0.05%
BAXBaxter International...+0.26+0.35%
MYLMylan NV-0.11-0.31%
Data as of 4:03pm ET, 07/20/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)$0.20
Annual revenue (last year)$1.5B
Annual profit (last year)-$313.1M
Net profit margin-20.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts